1. Home
  2. CDIO

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

Founded: 2017 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 11.6M IPO Year: N/A
Target Price: $2.00 AVG Volume (30 days): 179.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $0.17 - $3.56 Next Earning Date: 08-12-2024
Revenue: $32,993 Revenue Growth: 3372.95%
Revenue Growth (this year): 3459.39% Revenue Growth (next year): 202.27%

CDIO Daily Stock ML Predictions

Latest Cardio Diagnostics Holdings Inc. Common stock News

CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing

All CDIO News

Share on Social Networks: